Shionogi & Co. invested in Tokyo-based Restore Vision Inc., a startup developing visual restoration gene therapy using Chimeric Rhodopsin protein-based optical sensors to treat blindness from retinal disorders.
Source: phys. Original: https://phys.org/news/2026-04-unveil-ai-driven-coral-reef.html

